Premium
Prelude Therapeutics Inc (PRLD)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
| Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Return on Assets (%) | -178.959 | -144.055 | -46.385 | -42.253 | -43.926 | -48.912 |
| Return on Equity (%) | 129.379 | 76.472 | -69.95 | -44.85 | -47.966 | -56.335 |
| Return on Invested Capital (%) | -215.437 | -181.741 | -51.341 | -46.1 | -52.844 | -63.174 |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | 5.05 | 4.657 | 2.427 | 3.003 | 2.04 | 2.16 |
| Earnings Per Share | -5.332 | -7.539 | -0.651 | -1.173 | -1.205 | -1.11 |
| Cash Per Share | 5.665 | 5.162 | 2.498 | 0.334 | 0.319 | 0.23 |
| Working Capital Per Share | 4.776 | 4.208 | 2.396 | 2.898 | 1.907 | 1.948 |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | -5.332 | -7.539 | -0.651 | -1.173 | -1.205 | -1.11 |
| EBITDA Per Share | -5.332 | -7.539 | -0.651 | -1.173 | -1.205 | -1.11 |
| Free Cash Flow Per Share | -5.177 | -7.43 | -0.65 | -1.158 | -1.187 | -1.089 |
| Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
| Actions en circulation | 2,75M | 3,66M | 32,6M | 36,2M | 36,5M | 42,06M |
| Fin d'année 31 Décembre 2023 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 |
|---|---|---|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||
| Actions en circulation | 36,45M | 36,5M | 36,51M | 41,96M | 41,97M | 42,06M | 42,07M | 42,16M |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Capitalisation boursière | 37,64M |
| Ratio cours/bénéfice | -0,31 |
| Ratio prix/ventes | 0 |
| Ratio prix/liquidités | 1,48 |
| Ratio prix/valeur comptable | 0,16 |
| Rendement de dividende | - |
| Actions en circulation | 55,04M |
| Volume moyen (1 semaine) | 200,7k |
| Volume moyen (1 mois) | 209,38k |
| Variation sur 52 semaines | -85,16% |
| Plus haut sur 52 semaines | 6,80 |
| Plus bas sur 52 semaines | 0,6515 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
